Very true. And all that extra money is helping to fund companies like Mylan when they overprice the epi pen for several years. Why wouldn't they, customers ar

Very true. And all that extra money is helping to fund companies like Mylan when they overprice the epi pen for several years. Why wouldn't they, customers are insulated from the sticker price but can't really complain because high priced health "insurance" is required. It's just a coincidence that Mylan took any flak for its abuse of the system. Many other pharmaceuticals are increasing in price way out of proportion to inflation, and way out of step with reality since the R&D costs are all borne before product launch.